World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
70
Citations
15672
World Ranking
7092
National Ranking
3261

Overview

Zhenkun Lou is a researcher affiliated with Mayo Clinic in the United States, with a focus on biochemistry, genetics, molecular biology, and medicine. Their scholarly output spans multiple subfields, particularly molecular biology, oncology, pulmonary and respiratory medicine, cell biology, and immunology.

Their primary research topics include DNA repair mechanisms, PARP inhibition in cancer therapy, ubiquitin and proteasome pathways, CRISPR and genetic engineering, RNA modifications and cancer, cancer-related molecular pathways, and endoplasmic reticulum stress and disease.

Recent papers authored or co-authored by Zhenkun Lou include:

  • Metabolic regulation of homologous recombination repair by MRE11 lactylation, 2023, Cell
  • DNA end resection and its role in DNA replication and DSB repair choice in mammalian cells, 2020, Experimental & Molecular Medicine
  • Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC, 2020, Clinical Cancer Research
  • Regulation of sister chromatid cohesion by nuclear PD-L1, 2020, Cell Research
  • Extracellular matrix stiffness determines DNA repair efficiency and cellular sensitivity to genotoxic agents, 2020, Science Advances

Zhenkun Lou frequently collaborates with a group of co-authors, including:

  • Jake A. Kloeber
  • Xinyi Tu
  • Jinzhou Huang
  • Min Deng
  • Kuntian Luo

Their research is published in a range of scientific venues, with multiple publications in:

  • Cancer Research (7 publications)
  • Nature Communications (6 publications)
  • Nucleic Acids Research (5 publications)
  • Science Advances (4 publications)
  • Molecular Cell (4 publications)

Best Publications

  • MDC1 Maintains Genomic Stability by Participating in the Amplification of ATM-Dependent DNA Damage Signals

    Zhenkun Lou;Katherine Minter-Dykhouse;Sonia Franco;Monica Gostissa

  • FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt.

    Huadong Pei;Liang Li;Brooke L. Fridley;Gregory D. Jenkins

  • DBC1 is a negative regulator of SIRT1

    Ja Eun Kim;Junjie Chen;Zhenkun Lou

  • USP10 Regulates p53 Localization and Stability by Deubiquitinating p53

    Jian Yuan;Kuntian Luo;Lizhi Zhang;John C. Cheville

  • MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites

    Huadong Pei;Lindsey Zhang;Kuntian Luo;Yuxin Qin

  • MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways

    Zhenkun Lou;Katherine Minter-Dykhouse;Xianglin Wu;Junjie Chen

  • CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage

    Haojie Huang;Kevin M. Regan;Zhenkun Lou;Junjie Chen

  • Histone H3-K56 acetylation is important for genomic stability in mammals.

    Jian Yuan;Mintie Pu;Zhiguo Zhang;Zhenkun Lou

  • A c-Myc–SIRT1 feedback loop regulates cell growth and transformation

    Jian Yuan;Katherine Minter-Dykhouse;Zhenkun Lou

  • H2AX Prevents DNA Breaks from Progressing to Chromosome Breaks and Translocations

    Sonia Franco;Monica Gostissa;Shan Zha;David B. Lombard

  • Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice

    Carlos Escande;Claudia C S Chini;Veronica Nin;Katherine Minter Dykhouse

  • Sumoylation of MDC1 is important for proper DNA damage response.

    Kuntian Luo;Kuntian Luo;Haoxing Zhang;Liewei Wang;Jian Yuan;Jian Yuan

  • MDC1 regulates intra-S-phase checkpoint by targeting NBS1 to DNA double-strand breaks

    Liming Wu;Kuntian Luo;Zhenkun Lou;Junjie Chen

  • Mediator of DNA damage checkpoint protein 1 regulates BRCA1 localization and phosphorylation in DNA damage checkpoint control

    Zhenkun Lou;Claudia Christiano Silva Chini;Katherine Minter-Dykhouse;Junjie Chen

  • PD-L1 (B7-H1) Competes with the RNA Exosome to Regulate the DNA Damage Response and Can Be Targeted to Sensitize to Radiation or Chemotherapy

    Xinyi Tu;Bo Qin;Yong Zhang;Cheng Zhang

  • A conserved NAD+ binding pocket that regulates protein-protein interactions during aging

    Jun Li;Michael S. Bonkowski;Sébastien Moniot;Dapeng Zhang

  • MDC1 directs chromosome-wide silencing of the sex chromosomes in male germ cells

    Yosuke Ichijima;Yosuke Ichijima;Misako Ichijima;Misako Ichijima;Zhenkun Lou;André Nussenzweig

  • DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine

    Jia Yu;Bo Qin;Ann M. Moyer;Somaira Nowsheen

  • A Balance between Positive and Negative Signals in Cytotoxic Lymphocytes Regulates the Polarization of Lipid Rafts during the Development of Cell-Mediated Killing

    Zhenkun Lou;Dragan Jevremovic;Daniel D. Billadeau;Paul J. Leibson

  • BRCA1 participates in DNA decatenation.

    Zhenkun Lou;Katherine Minter-Dykhouse;Junjie Chen

Frequent Co-Authors

Liewei Wang
Liewei Wang Mayo Clinic
Junjie Chen
Junjie Chen The University of Texas MD Anderson Cancer Center
Judy C. Boughey
Judy C. Boughey Mayo Clinic
Jann N. Sarkaria
Jann N. Sarkaria Mayo Clinic
Saverio Bellusci
Saverio Bellusci University of Giessen
Zhiguo Zhang
Zhiguo Zhang Columbia University
Haidong Dong
Haidong Dong Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Zhenkun Lou

Trending Scientists